Related Experiment Videos
Using troponin T to diagnose acute coronary syndromes
E McErlean1, C F Van Lente, S E Nissen
1Department of Cardiology, Cleveland Clinic Foundation, OH 44195, USA. mcerlee@ccf.org
Insights
Elevated troponin T is a specific marker for acute myocardial infarction, useful even days later. Measuring both troponin T and creatine kinase MB provides crucial diagnostic information, especially in complex cases.
Area of Science:
- Cardiology
- Biomarkers
- Diagnostic Medicine
Background:
- Acute myocardial infarction diagnosis relies on cardiac biomarkers.
- Troponin T and creatine kinase MB (CK-MB) are key cardiac markers.
- Each marker has unique diagnostic advantages and limitations.
Purpose of the Study:
- To compare the diagnostic utility of troponin T and CK-MB in acute myocardial infarction.
- To present a diagnostic algorithm integrating both troponin T and CK-MB measurements.
- To highlight the importance of using both markers for comprehensive diagnosis.
Main Methods:
- Review of existing literature on cardiac biomarker assays.
- Analysis of troponin T and CK-MB performance characteristics.
- Development of a clinical decision algorithm based on marker levels and patient presentation.
Main Results:
- Troponin T offers higher specificity and a longer detection window for myocardial infarction compared to CK-MB.
- CK-MB remains valuable for estimating infarct size and diagnosing myocardial infarction in renal failure patients.
- Concurrent measurement of both troponin T and CK-MB provides complementary diagnostic information.
Conclusions:
- Troponin T is a superior marker for detecting acute myocardial infarction, particularly in late presentations.
- CK-MB retains essential roles in specific clinical scenarios, such as infarct sizing and renal failure.
- A combined approach utilizing a diagnostic algorithm for both troponin T and CK-MB enhances diagnostic accuracy for acute myocardial infarction.
Abstract:
Elevated troponin T is a useful marker for acute myocardial infarction: it is more specific than is elevated creatine kinase MB isoenzyme, and it remains elevated for many days after creatine kinase levels have returned to normal, providing a useful indicator for late presentations. Nevertheless, creatine kinase MB still has many important roles, including providing estimates of infarct size and diagnosing acute myocardial infarction in patients with renal failure. Often, measuring both markers provides additional information. This article provides a diagnostic algorithm for using both markers.